SCHEMBL4684243

SCHEMBL4684243

COc1cc(OCc2cccnc2)ccc1C(N)=O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP15 Q460N3 4/20 0.66
MKNK1 Q9BUB5 3/20 0.59
MKNK2 Q9HBH9 3/20 0.59
PARP10 Q53GL7 4/20 0.58
RECQL P46063 1/20 0.50
PARP14 Q460N5 1/20 0.49
GFER P55789 1/20 0.48
F9 P00740 1/20 0.48
F10 P00742 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CYP1A1 P04798 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP1B1 Q16678 1/20 0.48
CCNE1 P24864 1/20 0.48
CDK2 P24941 1/20 0.48
LRRK2 Q5S007 1/20 0.47
STING1 Q86WV6 1/20 0.47
GPR132 Q9UNW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12111212 0.86 PARP15 (0.52) PARP15RECQLGFERHSD17B10CYP1A1
SCHEMBL4686639 0.85 PARP15 (0.65) PARP15MKNK1MKNK2PARP10PARP14
SCHEMBL6140955 0.85 PARP15 (0.75) PARP15PARP10PARP14STING1
SCHEMBL4684246 0.79 MELK (0.51) F9F10HSD17B10CYP1A2CYP3A4
SCHEMBL8034556 0.78 PARP1 (0.61) GFERLRRK2ALDH1A1
SCHEMBL15474900 0.78 ALDH1A1 (0.52) HSD17B10GPR132ALDH1A1
SCHEMBL6776817 0.78 MAOB (0.53) RECQLHSD17B10GPR132ALDH1A1
SCHEMBL6141239 0.78 PARP15 (0.65) PARP15PARP10PARP14STING1
SCHEMBL3123583 0.78 L3MBTL1 (0.60) MKNK1MKNK2RECQLCYP1A2CYP3A4
SCHEMBL7900710 0.78 MAOB (0.71) RECQLCYP3A4GPR132ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805163-B1 1,1A,5,5A-TETRAHYDRO-3-THIA-CYCLOPROPA[A]PENTALENES: TRICYCLIC THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2008-10-01 EP claimed